Cellectar Biosciences INC NEW Share Price
NASDAQ: CLRBHealthcare
Live Cellectar Biosciences INC NEW Share Price Chart
O H L
Cellectar Biosciences INC NEW Performance Overview
Days Range
▼
$2.39Low
$2.42High
Markets Today
| Previous Close | $2.40 |
|---|---|
| Open | $2.39 |
| Volume | 71,669 |
| Day's Range | $2.39 - $2.42 |
| 52W Range | $2.20 - $6.52 |
| Market Cap | $22.21 M |
Historical Performance
| 1M Returns | -7.34 |
|---|---|
| 3M Returns | -13.98 |
| 6M Returns | -26.15 |
| 1Y Returns | -56.28 |
| 5Y Returns | -99.21 |
| 10Y Returns | -99.97 |
Cellectar Biosciences INC NEW Fundamentals
| Market Cap | $22.21 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -2.00 |
| EPS TTM | $-4.59 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.65 |
| EBITDA | $-22.77 M |
| Profit Margin | N/A |
| Market Cap | $22.21 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -2.00 |
| EPS TTM | $-4.59 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.65 |
| EBITDA | $-22.77 M |
| Profit Margin | N/A |
Cellectar Biosciences INC NEW Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$6.40 M | -$6.04 M | -$4.85 M | -$5.69 M | -$5.79 M | -$7.20 M |
| EBITDA | -$6.34 M | -$5.98 M | -$4.80 M | -$5.64 M | -$5.90 M | -$7.16 M |
| Interest Expense | $136.96 K | $0 | $0 | $0 | $63.00 K | $0 |
| Depreciation | $56.30 K | $55.56 K | $52.28 K | $49.46 K | -$110.02 K | $35.52 K |
| Income Before Tax | -$6.60 M | -$5.45 M | -$4.44 M | -$5.30 M | -$5.65 M | -$6.93 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$6.60 M | -$5.45 M | -$4.44 M | -$5.30 M | -$5.65 M | -$6.93 M |
| Net Profit Margin | - | - | - | - | - | - |
Cellectar Biosciences INC NEW Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $461 | $18 | $32 | $42 | $42 | $83 |
| Reserve & Surplus | -$253.95 M | -$259.39 M | -$263.84 M | -$269.13 M | -$274.79 M | -$281.72 M |
| Non-Current Liabilities | $386.20 K | $361.49 K | $335.89 K | $309.40 K | $1.53 M | $1.53 M |
| Current Liabilities | $6.02 M | $5.87 M | $4.91 M | $4.75 M | $4.87 M | $5.24 M |
| Total Liabilities | $6.41 M | $6.23 M | $5.25 M | $5.06 M | $6.40 M | $6.77 M |
| Fixed Assets | $700.83 K | $647.55 K | $595.27 K | $549.40 K | $339.70 K | $304.17 K |
| Current Assets | $14.89 M | $12.62 M | $13.62 M | $14.04 M | $9.27 M | $34.88 M |
| Total Assets | $16.04 M | $13.70 M | $14.63 M | $14.98 M | $11.12 M | $36.64 M |
Cellectar Biosciences INC NEW Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$6.60 M | -$5.45 M | -$4.44 M | -$5.30 M | -$5.65 M | -$6.93 M |
| Operating Cash Flow | -$9.38 M | -$5.12 M | -$4.28 M | -$4.34 M | -$4.85 M | -$6.01 M |
| Investing Cash Flow | $0 | $0 | $0 | -$5.88 K | -$3.38 K | $0 |
| Financing Cash Flow | $0 | $2.25 M | $5.79 M | $4.99 M | $0 | $31.66 M |
| Change in Cash | -$9.38 M | -$2.86 M | $1.51 M | $641.74 K | -$4.85 M | $25.65 M |
Cellectar Biosciences INC NEW Return Calculator
The Cellectar Biosciences INC NEW stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$78
Invested Amount$10,000
Est. Returns$-9,922
About Cellectar Biosciences INC NEW
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
Popular Stocks
FAQs
What is the share price of Cellectar Biosciences INC NEW today?
Cellectar Biosciences INC NEW (CLRB) share price as of September 18, 2026 is $2.35. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Cellectar Biosciences INC NEW?
Yes, Indian Investors can invest in the Cellectar Biosciences INC NEW (CLRB) Share by opening an international trading account with Angel One.
How can I purchase Cellectar Biosciences INC NEW shares in India?
Purchasing Cellectar Biosciences INC NEW (CLRB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Cellectar Biosciences INC NEW (CLRB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Cellectar Biosciences INC NEW?
Yes, you can purchase fractional shares of Cellectar Biosciences INC NEW (CLRB) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Cellectar Biosciences INC NEW?
The market capitalization of Cellectar Biosciences INC NEW on September 18, 2026, is $22.21 M.
In which sector Cellectar Biosciences INC NEW belongs?
Cellectar Biosciences INC NEW operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Cellectar Biosciences INC NEW stocks?
In order to invest in Cellectar Biosciences INC NEW (CLRB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
